High PTPN12 expression was described to be linked with favorable survival duration in non-small cell lung carcinoma patients [18] and with response to neoadjuvant chemotherapy in triple negative breast cancer [19]. This evidence concerns the gene PTPN12 and non-small cell lung carcinoma.